OMA1 Reporter Molecule for Mitochondrial Dysfunction Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting mitochondrial dysfunction, particularly OMA1 activity, are indirect, time-consuming, and costly, and lack sensitivity, making it difficult to assess mitochondrial fragmentation and cell death effectively.
Innovation Solution
Development of reporter molecules with a detection domain, a linker domain containing an OMA1 cleavage site, and a repressor domain that increases signal emission upon cleavage by OMA1, allowing for direct and efficient measurement of mitochondrial dysfunction and OMA1 activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If indirect methods such as western blotting are used to detect OMA1 activity through OPA1 processing status, then OMA1 activity can be measured, but the analysis is complicated by multiple proteases processing OPA1 and the method is time-consuming and costly
Solution Approach 1:
The reporter molecule is divided into distinct functional domains: a detection domain (fluorophore), a linker domain containing the OMA1-specific cleavage site, and a repressor domain. This segmentation allows the assay to specifically detect OMA1 activity while avoiding interference from other proteases, as each domain performs a dedicated function in the detection mechanism.
Solution Approach 2:
The invention introduces a specific peptide linker domain as an intermediary substrate that contains an OMA1-specific cleavage site. This intermediary molecule mediates the detection process by being specifically recognized and cleaved by OMA1, producing a fluorescent signal. This eliminates the need to analyze complex protein processing patterns and directly reports OMA1 activity.
2Measurement precision
If specialized cellular imaging techniques are used to assess mitochondrial fragmentation, then mitochondrial dysfunction can be detected, but the process is time-consuming and costly
Solution Approach 1:
The invention replaces complex mechanical imaging techniques with a biochemical fluorescence-based assay. Instead of using specialized cellular imaging equipment to visually assess mitochondrial fragmentation, the method uses a fluorescent reporter molecule that chemically responds to OMA1 activity, producing a quantifiable signal that can be measured with standard plate readers or fluorometers, dramatically reducing both time and cost.
Solution Approach 2:
The invention changes the detection parameter from visual/morphological assessment of mitochondrial fragmentation to a biochemical fluorescence intensity measurement. By monitoring the fluorescence signal generated upon OMA1 cleavage of the reporter molecule, the assay directly quantifies OMA1 activity as a surrogate for mitochondrial dysfunction, enabling high-throughput screening without specialized imaging equipment.
3Reliability
If current indirect methods are used for detecting mitochondrial dysfunction, then detection can be performed, but sensitivity is insufficient for effective assessment of mitochondrial fragmentation and cell death
Solution Approach 1:
The invention utilizes fluorescence emission as a detectable signal change. The reporter molecule contains a fluorophore that emits light upon excitation, and this fluorescence signal increases upon OMA1 cleavage of the linker domain. This optical signal change provides high sensitivity for detecting OMA1 activity and mitochondrial dysfunction, allowing detection in high-throughput formats with excellent signal-to-noise ratios.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables sensitive and direct detection of mitochondrial dysfunction and OMA1 activity, facilitating high-throughput screening for drug discovery and disease detection associated with mitochondrial dysfunction.
Implementation Method 1
at least one detection domain capable of emitting a signal
Data Source
AI summary
The present disclosure relates to methods and compositions for detecting mitochondrial dysfunction. In particular, the disclosure relates to reporter molecules that are cleavable by the zinc metalloprotease Metalloendopeptidase OMA1 (OMA1). In each embodiment, the reporter molecules of the invention are particularly useful for drug discovery and detection of diseases associated with mitochondrial dysfunction.